Document is current
Any future updates will be listed below
-
Authors
Irwin, Ronald W.
Shah, Unnati H.
Soni, Shivani
Lenz, Heinz Josef
Shih, Jean C. https://orcid.org/0000-0003-2952-3246
-
Funding
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (P30CA014089)
School of Pharmacy, University of Southern California
University of Southern California
- License Information
-
More Information
Article History
Received: 14 June 2024
Accepted: 25 January 2025
First Online: 4 February 2025
Declarations
:
: There are patents and products in development. Patents issued on monoamine oxidase inhibitors as therapeutics for brain cancer and other cancers. The authors report the following patent relevant to this research: “Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer (US20180185303A1)”; “MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer” (Patent number: US 2020/10561663 B2).
